Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 048000/0033 | |
| Pages: | 6 |
| | Recorded: | 12/28/2018 | | |
| Attorney Dkt #: | SCOT.P0012US.D1/11600239 |
| Conveyance: | CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME PREVIOUSLY RECORDED ON REEL 042274 FRAME 0278. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
04/30/2019
|
Application #:
|
15090058
|
Filing Dt:
|
04/04/2016
|
|
Publication #:
|
|
Pub Dt:
|
11/03/2016
| | | | |
|
Title:
|
ANTIBODIES TO TUMOR ENDOTHELIAL MARKER 8
|
|
|
Assignee
|
|
|
|
|
| 6011 EXECUTIVE BOULEVARD |
| SUITE 325, MSC 7660 |
| BETHESDA, MARYLAND 20892-7660 |
|
|
Correspondence name and address
|
| |
NORTON ROSE FULBRIGHT US LLP
|
| |
98 SAN JACINTO BLVD.
|
| |
SUITE 1100
|
| |
AUSTIN, TX 78701
|
Search Results as of:
05/04/2024 08:14 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
